You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
Wrong country/market login message
What's New with Roche Pathology Lab
Our mission is to improve the lives of all patients with cancer. Roche is investing in every step of the patient journey to meet the evolving needs of labs and patients.
VENTANA PD-L1 (SP263)
VENTANA PD-L1 (SP263) Assay is intended for the qualitative detection of the programmed death ligand 1 (PD-L1) protein in formalin-fixed, paraffin-embedded (FFPE) non-small cell lung cancer (NSCLC), urothelial carcinoma (UC) and other tumor tissues stained with OptiView DAB IHC Detection Kit on a BenchMark IHC/ISH instrument.
PATHWAY anti-HER2 (4B5) antibody
PATHWAY HER2/neu (4B5) Rabbit Monoclonal Primary Antibody is a pre-diluted reagent for use on the Roche BenchMark IHC/ISH automated slide staining instruments.
VENTANA HER2 DUAL ISH DNA Probe Cocktail
The VENTANA HER2 Dual ISH DNA Probe Cocktail assay is a fully automated, ready-to-use brightfield solution for determining HER2 gene status.
VENTANA MMR RxDx Panel
Cancer continues to be a significant societal challenge as the 2nd leading cause of death in the United States and worldwide.1 In the US, approximately 1.9 million new cancer cases were expected to be diagnosed in 2022.1 Of these cases, the vast majority will consist of solid tumors, approximately 14% of which will have been shown to have defects in any of the MMR proteins.
VENTANA FOLR1 (FOLR1-2.1) RxDx Assay
Roche today announced U.S. Food and Drug Administration (FDA) approval of the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, the first immunohistochemistry (IHC) companion diagnostic test to aid in identifying epithelial ovarian cancer (EOC) patients who are eligible for targeted treatment with ELAHERE™ (mirvetuximab soravtansine-gynx).
Anti-PRAME (EPR20330) Rabbit Monoclonal Primary Antibody
PRAME (PReferentially expressed Antigen in MElanoma) is a tumor biomarker expressed in most cutaneous and ocular melanomas.
PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody Identifying HER2-low expression
We have been making advancements in HER2 testing, breast cancer research, and treatment since 1990. Discover our history, innovations, and current HER2 efforts.
BenchMark ULTRA PLUS
The BenchMark ULTRA PLUS system uses an unprecedented, fully-automated workflow for immunohistochemistry (IHC) and in-situ hybridization (ISH) slide staining to decrease touchpoints.
VENTANA DP 600 slide scanner
Workflow flexibility meets high-capacity with the VENTANA DP 600 slide scanner featuring a slide tray-based system and built-in calibrations.
See all BenchMark ULTRA Plus migrated products
To play the media you will need to either update your browser to a recent version or update your
Learn more about innovation across the Roche Group
Sign up for our quarterly newsletter
Form Successfully Submitted!
Thank you for your submission!
Some randomr randomr randomr randomr randomr randomr